Fly News Breaks for July 24, 2017
HCP
Jul 24, 2017 | 06:47 EDT
Goldman analyst Andrew Rosivach downgraded HCP to Neutral and trimmed its price target to $32 from $35 saying legacy issues related to "HCP 2.0" investments will continue to impact earnings negatively and expects shares to pause as the market digests and earnings rebase.
News For HCP From the Last 2 Days